Tan DHS - Search Results

1

Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial.

Tan DHS, Raboud JM, Szadkowski L, Grinsztejn B, Madruga JV, Figueroa MI, Cahn P, Barton SE, Clarke A, Fox J, Zubyk W, Walmsley SL; VALIDATE Study Group. Tan DHS, et al. J Antimicrob Chemother. 2019 Feb 1;74(2):480-488. doi: 10.1093/jac/dky433. J Antimicrob Chemother. 2019. PMID: 30376108 Free PMC article. Clinical Trial.

2

Response to Stegmann s, et Al. [J. Clin. Virol. 47 (1) (2010) 79-81].

Tan DH, Walmsley SL. Tan DH, et al. J Clin Virol. 2010 Mar;47(3):297-8. doi: 10.1016/j.jcv.2009.12.016. Epub 2010 Jan 15. J Clin Virol. 2010. PMID: 20079687 No abstract available.

3

Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial.

Tan DH, Raboud JM, Kaul R, Grinsztejn B, Cahn P, Walmsley SL. Tan DH, et al. Trials. 2010 Nov 24;11:113. doi: 10.1186/1745-6215-11-113. Trials. 2010. PMID: 21106086 Free PMC article. Clinical Trial.

4

No impact of oral tenofovir disoproxil fumarate on herpes simplex virus shedding in HIV-infected adults.

Tan DH, Kaul R, Raboud JM, Walmsley SL. Tan DH, et al. AIDS. 2011 Jan 14;25(2):207-10. doi: 10.1097/QAD.0b013e328341ddf7. AIDS. 2011. PMID: 21150556

5

Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy.

Tan DH, Chan K, Raboud J, Cooper C, Montaner JS, Walmsley S, Hogg RS, Klein MB, Machouf N, Rourke SB, Tsoukas C, Loutfy MR; CANOC Collaboration. Tan DH, et al. J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):38-46. doi: 10.1097/QAI.0b013e3182282cfc. J Acquir Immune Defic Syndr. 2011. PMID: 21709570

6

Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection.

Tan DH, Raboud JM, Kaul R, Brunetta J, Kaushic C, Kovacs C, Lee E, Luetkehoelter J, Rachlis A, Smaill F, Smieja M, Walmsley SL. Tan DH, et al. Clin Infect Dis. 2013 Aug;57(3):448-57. doi: 10.1093/cid/cit208. Epub 2013 Apr 9. Clin Infect Dis. 2013. PMID: 23572481

7

Management of persons infected with human immunodeficiency virus requiring admission to the intensive care unit.

Tan DH, Walmsley SL. Tan DH, et al. Crit Care Clin. 2013 Jul;29(3):603-20. doi: 10.1016/j.ccc.2013.03.010. Epub 2013 May 8. Crit Care Clin. 2013. PMID: 23830655 Review.

8

A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.

Yi TJ, Walmsley S, Szadkowski L, Raboud J, Rajwans N, Shannon B, Kumar S, Kain KC, Kaul R, Tan DH. Yi TJ, et al. Clin Infect Dis. 2013 Nov;57(9):1331-8. doi: 10.1093/cid/cit539. Epub 2013 Aug 14. Clin Infect Dis. 2013. PMID: 23946220 Clinical Trial.

9

Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study.

Tan DH, Raboud JM, Kaul R, Walmsley SL. Tan DH, et al. BMJ Open. 2014 Jan 24;4(1):e004210. doi: 10.1136/bmjopen-2013-004210. BMJ Open. 2014. PMID: 24464523 Free PMC article.

10

Herpes simplex virus type 2 serostatus is not associated with inflammatory or metabolic markers in antiretroviral therapy-treated HIV.

Tan DH, Raboud JM, Szadkowski L, Yi TJ, Shannon B, Kaul R, Liles WC, Walmsley SL. Tan DH, et al. AIDS Res Hum Retroviruses. 2015 Mar;31(3):276-81. doi: 10.1089/AID.2014.0183. Epub 2014 Dec 17. AIDS Res Hum Retroviruses. 2015. PMID: 25399537 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters